U.S. Court in New York Rejects Safety Net Providers' Antitrust Action Against Drug Makers over 340B Discounts
- September 09, 2022
A federal court in New York dismissed an action brought by "safety net" providers alleging that four pharmaceutical companies violated federal and state antitrust laws by coordinating to rescind long-standing discounts under the 340B program.
ARTICLE TAGS
You must be logged in to access this content.